Skip to main content
. 2021 Jul 29;11(7):e048719. doi: 10.1136/bmjopen-2021-048719

Figure 3.

Figure 3

Subgroup analysis of MACE with aspirin use in patients with VSA. MACE, major cardiovascular adverse events; VSA, vasospastic angina.